Jon Heal

Jon Heal is the Head of In Silico Design at RxCelerate Ltd and has held the position since 2019. They served as EVP in Silico at ProsaRx since 2019, after transitioning from their roles as CSO at Evolva Bio UK Ltd and Prosarix Ltd, where they contributed from 2016 to 2018 and 2007 to 2016, respectively. Jon was also a founding member and CSO at Proteom Ltd from 1999 to 2005 and served as Director of Informatics at Amura Ltd from 2005 to 2007. They earned a PhD in Chemistry and a 1st Class Honours BSc from Imperial College London, where they studied from 1991 to 1998.